More PRNewswire
View Older Stories View Newer Stories-
Remplir™ Study Delivers Compelling 81% Success Rate
-
Acer Reports Revenues for August at NT$21.80 Billion, and Year-to-August at NT$171.74 Billion
-
ADNOC Gas to Join FTSE Emerging Index, Unlocking Over $250 Million in Fund Investment
-
The Rainforest Alliance Announces Regenerative Agriculture Certification for Coffee
-
Otis Chosen by Mountain View for Egyptian Real Estate Projects
-
MDA SPACE APPOINTS ANDREW STANNILAND AS MANAGING DIRECTOR, MDA SPACE UK
-
Guild Garage Group Announces Partnership with Door Serv Pro
-
Sendmarc appoints Rob Bowker as North American Region Lead
-
OranAI Raises Multi-Million-Dollar Angel Funding to Lead AI Content Marketing Through Its AI Agent PhotoG
-
Altalto advances as UK's leading waste-to-SAF project with new government funding and NEXTCHEM partnership
-
Envalior publishes its first Sustainability Report
-
Strathcona Resources Ltd. Announces Amended and Extended Offer to Acquire MEG Energy Corp.
-
SPJIMR retains #35 global rank, among top 3 in India in FT MiM 2025 global ranking
-
JETOUR G700 Rolls Out to the Middle East, Setting a New Benchmark for Hybrid Off-Road
-
Backpack EU Goes Live, Offering Regulated Perpetuals Trading for European Traders
-
Denise Boomkens launches The Guide, a new vision of aging for women 40+
-
DuRoBo Debuts Krono: A 6.13" ePaper Focus Hub for Clarity and Calm
-
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
-
Kea Raises €6M in Extended Seed Round at €40M Valuation to Scale Its Crypto-Friendly Core Banking Infrastructure
-
SKF to showcase scalable, customer-focused innovations at 2025 Tech and Innovation Summit
-
New York's Cassie Donegan Wins Miss America 2026
-
Gushengtang's H1 2025 Net Profit Climbs 41.6% Driven by Digital Health Adoption and International Expansion
-
Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025
-
Repurchase of Truecaller B shares in week 36, 2025
-
Beko introduces its next generation of appliances driving energy savings and environmental responsibility
-
This Week: The Entire Metals Supply Chain Meets at UK Metals Expo, NEC Birmingham
-
Verve appoints Michael Pring as Global Client & Development Director
-
DFI Unveils Upcoming Rugged Edge AI Platforms for Mission-Critical Computing
-
Dreame Washer&Dryer Set L9 Debuts at IFA 2025 -- Redefining High-End Laundry with Cutting-Edge Tech
-
Monster Energy's Marine Cabirou Takes Third Place at 2025 UCI Mountain Bike World Championships in Valais, Switzerland
-
BNG Bank Interim report 2025:
-
accesso® Names Mike Evenson as Chief Commercial Officer
-
A NEW ERA OF INNOVATION: STARS OF SCIENCE RETURNS FOR SEASON 17
-
Confidence in the US-UK Corridor Takes a Hit - 2025 Transatlantic Confidence Index
-
The9 Web3.5 GameFi Platform the9bit Hits 2 Million Users
-
Omya Performance Polymer Distribution to Make Official Debut at K-Fair 2025
-
Ground Support Labs and Moving Walls Partner to Launch XEN Media, the First End-to- End Platform for Digital Out-of-Home Network Owners in the U.S.
-
AVATR VISION XPECTRA Makes Global Debut, AVATR Showcasing Original Design in Munich
-
Accion Announces Close of $61.6M Second Accion Venture Lab Fund Investing in Early-Stage Inclusive Fintech
-
HashKey Unveils DAT Strategy: Pioneering the Institutional Bridge Between TradFi and Crypto
-
Sirnaomics Announces Strategic Equity Investment by Bloomage Biotech to Jointly Advance Next-Generation Life Science Pipelines
-
Eisai Presents Clinical Study Results of Novel Orexin Receptor Agonist E2086 for Narcolepsy at World Sleep 2025
-
Commitment to Investor
-
Fujitsu develops generative AI reconstruction technology for optimized and energy-efficient AI models based on Takane LLM
-
Epigenic Therapeutics Announces Completion of $60 Million Series B Financing to Accelerate Clinical Development of Epigenetic Medicines
-
WSPN Completes Acquisition of Aplauz NL B.V.
-
Sunset World Group Reports Progress on the 2025 Sea Turtle Nesting Season
-
Innovent Announces Phase 2 Results of Tigulixostat (IBI128, XOI) in Gout Patients were Published at the 27th Asia-Pacific League of Associations for Rheumatology Congress
-
Hugel strengthens Brazil presence with Letybo launch and new partner Derma Dream
-
Baidu Announces Proposed Offering of CNY-denominated Senior Notes
